|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|
| Revenue | |||
| Product sales | |||
| Contract research and development | |||
| Total contract research and development | |||
| Total revenue, net | |||
| Cost of sales | |||
| Gross profit | |||
| Expenses | |||
| Research and development | |||
| Selling, general, and administrative | |||
| Credit loss expense | |||
| Total expenses | |||
| Income from operations | |||
| Interest income | |||
| Other income | |||
| Income before taxes | |||
| Provision for income taxes | |||
| Net income | |||
| Net income per share - basic | |||
| Net income per share - diluted | |||
| Weighted Average Number of Shares Outstanding, Basic | |||
| Weighted Average Number of Shares Outstanding, Diluted | |||
Loading...
